BRAY, MARK R.,BROKX, RICHARD,LAUFER, RADOSLAW,LI, SZE-WAN,MASON, JACQUELINE M.,NG, GRACE,PAULS, HEINZ W.
申请号：
CA2964282
公开号：
CA2964282A1
申请日:
2015.10.09
申请国别(地区):
CA
年份:
2016
代理人:
摘要：
The invention is a compound represented by Structural Formula (I): (I)； or a pharmaceutically acceptable salt thereof. Values for the variables are provided herein. Also included is a pharmaceutical composition comprising the compound represented by Structural Formula (I) and a pharmaceutically acceptable carrier or diluent and methods of treating a subject with cancer with the compound of Structural Formula (I).
